Invention Grant
- Patent Title: Polysaccharide immunogens conjugated to E. coli carrier proteins
- Patent Title (中): 与大肠杆菌载体蛋白结合的多糖免疫原
-
Application No.: US13520338Application Date: 2010-12-30
-
Publication No.: US09173954B2Publication Date: 2015-11-03
- Inventor: Paolo Costantino , Francesco Berti , Francesca Micoli , Anna Kabanova , Laura Serino , Maria Rosaria Romano , Marta Tontini
- Applicant: Paolo Costantino , Francesco Berti , Francesca Micoli , Anna Kabanova , Laura Serino , Maria Rosaria Romano , Marta Tontini
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee Address: BE Rixensart
- Agency: Morrison & Foerster LLP
- International Application: PCT/IB2010/003484 WO 20101230
- International Announcement: WO2011/080595 WO 20110707
- Main IPC: A61K47/48
- IPC: A61K47/48 ; A61K39/108 ; A61K39/00 ; A61K39/39

Abstract:
E. coli proteins have been identified that are useful as carrier proteins to improve a response to a polysaccharide immunogen conjugated to such protein. In particular, AcfD precursor protein (orf3526 polypeptide), Flu antigen 43 protein (orf1364 polypeptide), and Sel1 repeat-containing protein (upec-5211 polypeptide) have been shown to be effective. Additionally, these E. coli proteins can enhance the immune response to glucans, particularly fungal glucans.
Public/Granted literature
- US20120308600A1 POLYSACCHARIDE IMMUNOGENS CONJUGATED TO E. COLI CARRIER PROTEINS Public/Granted day:2012-12-06
Information query